by Bernardo Garcia Finanzas Personales | 24/03/2025 12:59 PM | TSLA
🚗 Tesla is under scrutiny as the FBI investigates threats and incidents involving the company, including vandalism at its facilities.
📈 Despite these challenges, Tesla's stock has risen by 10%, reflecting strong market confidence and potential growth opportunities.
🌍 The company's global operations and strategic decisions continue to attract significant attention and debate among investors.
Read more!
by Bernardo Garcia Finanzas Personales | 24/03/2025 12:59 PM | MSFT
💰 Microsoft offers a dividend yield nearing 1%, with a history of annual increases by 10%, showcasing its commitment to shareholder returns.
📊 The company's financial stability and consistent dividend growth make it an attractive option for long-term investors.
📈 Microsoft's strategic positioning in technology and cloud services continues to drive its market performance and investor confidence.
Read more!
by Bernardo Garcia Finanzas Personales | 24/03/2025 04:00 AM | TSLA
🚗 Tesla announced the introduction of its Full Self-Driving (FSD) function in China after obtaining the necessary software approval.
✅ This announcement was made through the company's customer service account on We, in response to a report on the suspension of a free trial of the FSD service.
🇨🇳 The suspension of the initial test (March 17 to April 16) aligns with new regulations issued by the Chinese ministry that require regulatory authorization for wireless software updates before their implementation.
Read more!
by Bernardo Garcia Finanzas Personales | 24/03/2025 04:00 AM | META
🤖 Korean chip startup Furiosa AI rejected an $800 million acquisition offer from Meta.
🤝 Meta had apparently been negotiating the acquisition of Furiosa AI, based in Seoul, since the beginning of this year.
📈 Furiosa AI opted to expand the business as an independent company, showing Meta's interest in manufacturing its own chips.
Read more!
by Bernardo Garcia Finanzas Personales | 24/03/2025 04:00 AM | ME
📉 23andMe declared bankruptcy with a current market valuation of just under $50 million, a drastic drop from its $6 billion valuation after a SPAC merger.
🧬 The company, led by Ms. Ana, promised to revolutionize the healthcare sector with its affordable DNA tests that detailed genetic lineage and were intended to develop drugs tailored to the company's research.
❌ The executive board rejected the CEO's purchase price, leading to uncertainty and, ultimately, the company's downfall.
Read more!